Leveraging A Digital Pill System to Understand Prevention-Effective Adherence to Oral Hiv Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Substance Use

Daily oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, though efficacy depends on adherence. Digital pill systems (DPS) can enable direct, real-time adherence measurement. HIV-negative men who have sex with men (MSM) with substance use (excluding alcohol) utilized a DPS o...

Full description

Saved in:
Bibliographic Details
Published inAIDS and behavior Vol. 28; no. 10; pp. 3373 - 3380
Main Authors Chai, Peter R., Goodman, Georgia R., Mohamed, Yassir, Bustamante, Maria J., Albrechta, Hannah, Lee, Jasper S., Glynn, Tiffany R., Boland, Kel, Hokayem, Joanne, Boyer, Edward W., Rosen, Rochelle K., Mayer, Kenneth H., O’Cleirigh, Conall
Format Journal Article
LanguageEnglish
Published New York Springer US 01.10.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Daily oral pre-exposure prophylaxis (PrEP) is highly effective for HIV prevention, though efficacy depends on adherence. Digital pill systems (DPS) can enable direct, real-time adherence measurement. HIV-negative men who have sex with men (MSM) with substance use (excluding alcohol) utilized a DPS over 90 days and completed weekly surveys reporting sexual activity, condom use, and substance use. Responses indicating (1) any sexual activity and substance use or (2) condomless anal intercourse (CAI) in the prior week were categorized as high risk for HIV acquisition. PrEP adherence data for the 7-day period preceding each response was dichotomized as ≤ 3 and ≥ 4 doses/week, indicating prevention-effective adherence, and compared by HIV risk level. Thirteen MSM were analyzed (median age: 32). Of 113 surveys, 48.7% indicated high HIV risk, with 12.4% reporting CAI alone, 16.8% any sexual activity and substance use, and 19.5% both CAI and substance use. Weekly mean PrEP adherence was 90.3% (6.3 of 7 doses/week), with ≥ 4 doses/week recorded during 92.0% of weeks. The proportion of participants with ≥ 4 recorded doses/week was 88.9% during weeks with CAI alone, 89.5% during weeks with any sexual activity and substance use, 92.0% during weeks with both CAI and substance use, and 92.8% during lower risk weeks. Participants ingested ≥ 4 doses/week during 89.1% of all high-risk weeks and 94.8% of low-risk weeks. Overall, participants maintained high levels of PrEP adherence while engaging in HIV risk behaviors. DPS can be deployed concurrently with data collection tools to assess ingestion patterns during periods of elevated risk.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author Contributions Peter R. Chai was the principal investigator and was responsible for the study conception and design. Conall O’Cleirigh, Kenneth H. Mayer, Rochelle K. Rosen, and Edward W. Boyer contributed to the study conception and design. Georgia R. Goodman, Yassir Mohamed, and Maria J. Bustamante contributed to the study methodology and data collection, and data management. Yassir Mohamed, Georgia R. Goodman, and Jasper S. Lee conducted the analyses, with oversight from Peter R. Chai. Peter R. Chai, Georgia R. Goodman, and Yassir Mohamed wrote the first draft of the manuscript, with contributions and editing from all authors. All authors reviewed and approved the final manuscript.
ISSN:1090-7165
1573-3254
1573-3254
DOI:10.1007/s10461-024-04435-7